相关实验视频
Updated: Sep 11, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.6K
深度大脑刺激对帕金森病患者非运动症状的长期影响
Tanaya Mishra1, Nitish Kamble1, Ravi Yadav1
1Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bengaluru, Karnataka, India.
Annals of Indian Academy of Neurology
|August 18, 2025
概括
深度大脑刺激 (DBS) 在帕金森病 (PD) 患者中显著改善运动症状和长期非运动症状 (NMS). 这种治疗改善了PD患者的整体生活质量.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
背景情况:
- 深度大脑刺激 (DBS) 是一种成熟的帕金森病 (PD) 治疗方法,主要以改善运动症状而闻名.
- 在PD患者中,DBS对非运动症状 (NMS) 的长期影响需要进一步研究.
研究的目的:
- 评估DBS对帕金森病患者各种非运动症状 (NMS) 的长期影响.
主要方法:
- 一项雄心勃勃的研究包括36名接受DBS.PD的PD患者.
- 评估了患者的运动和9个非运动尺度,手术后的平均随访时间为51.78个月.
- 对比了NMS的DBS前和DBS后的得分.
主要成果:
- DBS显示了运动症状的持续改善.
- 在NMS中观察到显著的改善,包括白天嗜睡,睡眠质量,生活质量,抑郁,焦虑和冲动控制障碍.
- 在非运动症状尺度 (NMSS) 的情绪,胃肠道和各种领域中也注意到了积极的影响.
结论:
- 深度大脑刺激 (DBS) 对帕金森病 (PD) 患者的非运动症状 (NMS) 提供了长期的好处,超出了其已建立的运动改善.
- DBS有助于改善帕金森病患者的生活质量.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.9K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.0K
相关概念视频
01:24Parkinson's Disease: Treatment
377
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
377
01:15Parkinson's Disease: Overview
703
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
703